Differentiation of Glioblastomas and Metastases using 1H-MRS spectral data

Hydrogen-1 magnetic resonance spectroscopy (1H-MRS) allows noninvasive in vivo quantification of metabolite concentrations in brain tissue. In this work two of the most aggressive brain tumors are studied with the purpose of differentiating them. The challenging aspect in this task resides in that their radiological appearance is often similar, despite the fact that treatment of patients suffering these conditions is quite different. Efforts to differentiate between these two profiles are getting increasing attention, mainly because the consequences of performing an incorrect diagnosis. Due to the high dimensionality, initiatives oriented to reduce the description complexity become important. In this work we present a feature selection algorithm that generates relevant subsets of spectral frequencies. Experimental results deliver models that are both simple in terms of numbers of frequencies and show good generalization capabilities.

[1]  Alfredo Vellido Alcacena,et al.  Discriminating glioblastomas from metastases in a SV1H-MRS brain tumour database , 2009 .

[2]  M. Castillo,et al.  Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[3]  Josef Kittler,et al.  Floating search methods in feature selection , 1994, Pattern Recognit. Lett..

[4]  Lluís A. Belanche Muñoz,et al.  Outlier exploration and diagnostic classification of a multi-centre 1H-MRS brain tumour database , 2009, Neurocomputing.

[5]  Klaas Nicolay,et al.  1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.

[6]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[7]  Sungheon Kim,et al.  Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging , 2009, NeuroImage.

[8]  L. D.,et al.  Brain tumors , 2005, Psychiatric Quarterly.

[9]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[10]  M. Berger,et al.  Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2007, American Journal of Neuroradiology.

[11]  A. W. Simonetti,et al.  Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra , 2006, NMR in biomedicine.

[12]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[13]  D. Louis WHO classification of tumours of the central nervous system , 2007 .

[14]  F. Howe,et al.  Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.